MANCAN2:指导性自助认知行为疗法管理接受雄激素剥夺治疗的前列腺癌患者潮热盗汗影响的多中心随机对照试验
MANCAN2是一项III期多中心随机对照试验及过程评估,计划纳入144至196名正在接受雄激素剥夺治疗(ADT)且存在困扰性潮热盗汗(HFNS)的前列腺癌患者,按1:1随机分为常规治疗(TAU)组或指导性自助认知行为疗法(CBT)联合TAU组,由现有NHS前列腺癌专科护士(CNS)团队实施干预,并评估其有效性、实施保真度、成本效果及参与者依从性。
要点
- MANCAN2检验培训现有NHS前列腺癌CNS团队实施指导性自助CBT能否减轻ADT所致HFNS的影响。
- 计划纳入144至196名正在接受ADT且存在困扰性HFNS的前列腺癌患者,按1:1随机分组。
- 试验同时开展基于规范化过程理论框架的过程评估、实施保真度评估和成本效果评估。
核心结论
- MANCAN2将确定由现有NHS前列腺癌CNS团队在多中心研究中实施的指导性自助CBT干预能否减轻前列腺癌患者ADT所致HFNS的严重程度。
- 原文指出,若该干预成功,强调依托现有团队应有助于转化为常规实践中的实施。
研究设计与样本
- MANCAN2是一项III期多中心随机对照试验及过程评估。
- 计划纳入144至196名正在接受ADT且存在困扰性HFNS的前列腺癌患者,按1:1比例以6至8名参与者为一组进行个体随机。
- 参与者被随机分配至常规治疗(TAU)组或指导性自助CBT干预联合TAU组。
- 将采用规范化过程理论(NPT)框架开展过程评估,以了解CNS团队实施干预的体验并确定其作为常规实践服务实施的关键影响因素。
- 干预实施的保真度将由专家评估进行,同时评估干预的成本效果和参与者对试验干预的依从性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Androgen deprivation therapy (ADT) is prescribed to almost half of all men diagnosed with prostate cancer. Although ADT is effective treatment, with virtually all men with advanced disease showing initial clinical response, it is associated with troublesome side effects including hot flushes and night sweats (HFNS). HFNS can be both frequent and severe and can have a significant impact on quality of life (QoL). They can occasionally be so debilitating that patients stop ADT altogether, despite the increased risk of disease relapse or death. Previous research has found that guided self-help cognitive behavioural therapy (CBT) can be effective in reducing HFNS due to ADT when delivered by a clinical psychologist. MANCAN2 aims test whether we can train the existing NHS Prostate Cancer Nurse Specialist (CNS) team to deliver guided self-help CBT and whether it is effective in reducing the impact of HFNS in men undergoing ADT. METHODS: MANCAN2 is a phase III multicentre randomised controlled trial and process evaluation. Between 144 and 196 men with prostate cancer who are currently receiving ADT and are experiencing problematic HFNS will be individually randomised in a 1:1 ratio in groups of 6-8 participants to either treatment as usual (TAU) or participation in the guided self-help CBT intervention plus TAU. A process evaluation using the normalisation process theory (NPT) framework will be conducted, to understand the CNS team's experiences of delivering the intervention and to establish the key influencers to its implementation as a routine practice service. Fidelity of implementation of the intervention will be conducted by expert assessment. The cost-effectiveness of the intervention and participant adherence to the trial intervention will also be assessed. DISCUSSION: MANCAN2 will advance the program of work already conducted in development of management strategies for HFNS. This research will determine whether the severity of ADT-induced HFNS in men with prostate cancer can be reduced by a guided self-help CBT intervention, delivered by the existing NHS prostate cancer CNS team, within a multicentre study. The emphasis on this existing team, if successful, should facilitate translation through to implementation in routine practice. TRIAL REGISTRATION: ISRCTN reference 58720120 . Registered 13 December 2022.
引用
- Crabb S, Morgan A, Hunter MS, et al. A multicentre randomised controlled trial of a guided self-help cognitive behavioural therapy to MANage the impact of hot flushes and night sweats in patients with prostate CANcer undergoing androgen deprivation therapy (MANCAN2). Trials. 2023. PMID: 37430353. doi:10.1186/s13063-023-07325-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。